EmeraMed

About:

EmeraMed Limited is a biotechnology firm developing the metal chelator and antioxidant Irminix.

Twitter/X: emeramed

Top Investors: EASME - EU Executive Agency for SMEs

Description:

EmeraMed Limited is a privately held limited liability company (corporation) organized and headquartered in the Republic of Ireland. The Company currently operates in Ireland, Sweden, and the United States. The Company’s ownership group is primarily composed of physicians, dentists, and patients with personal experience of the product from when it was previously sold as a dietary supplement. If you are interested in learning more about the Company, please use our Contact page to request additional information.

Total Funding Amount:

$3.67M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Ranelagh, Dublin, Ireland

Founded Date:

2007-01-01

Contact Email:

info(AT)emeramed.com

Founders:

Boyd Haley

Number of Employees:

1-10

Last Funding Date:

2019-01-01

IPO Status:

Private

Industries: